Product Description
Doxofylline WHO GMP is an acclaimed, highly recommended bronchodilator recognized for its stellar efficacy in respiratory care. This distinguished pharmaceutical-grade compound, widely accessed by professionals, is manufactured under strict WHO GMP standards and surpasses international pharmacopoeia requirements. Presented as a brilliant white crystalline powder, it boasts superior purity (99%) and stability, making it ideal for tablets and syrups. Its non-poisonous, odorless profile-combined with low impurity levels-ensures safe formulation for asthma and COPD management. Available in sealed LDPE bags within HDPE drums (25kg), it is highly suitable for distributors, exporters, and manufacturers worldwide.
Versatile Application & Distinguished Features
Doxofylline WHO GMP showcases its excellence across a wide area of respiratory applications, especially in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Perfect for oral dosage forms such as tablets and syrups, this pharmaceutical-grade substance features a neutral pH, is highly soluble in water, and stable at room temperature. Its non-caffeine xanthine derivative nature and stellar safety profile make it a brilliant choice for varied therapeutic and formulation requirements.
Sample, Delivery, and Export Excellence
Samples of Doxofylline WHO GMP are accessible for evaluation with prompt quotation. The product is available for quick dispatch, ensuring rapid delivery to clients both in India and on major export markets globally. Flexible payment terms are provided, catering to distributors, wholesalers, importers, and suppliers. Our commitment to efficient logistics and comprehensive service guarantees a smooth, timely experience for buyers seeking renowned respiratory therapy ingredients.
FAQ's of Doxofylline WHO GMP:
Q: How does Doxofylline benefit patients with asthma and COPD?
A: Doxofylline acts as a bronchodilator, relaxing respiratory muscles to improve airflow and ease breathing in patients suffering from asthma and chronic obstructive pulmonary disease (COPD).
Q: What are the main applications of Doxofylline WHO GMP?
A: This product is primarily used in pharmaceutical formulations like tablets and syrups intended for respiratory therapy, particularly in the management of asthma and COPD.
Q: Where is Doxofylline WHO GMP manufactured and what certifications does it hold?
A: Doxofylline WHO GMP is manufactured in India and meets stringent WHO GMP and International Pharmacopoeia standards, ensuring high quality and compliance.
Q: How is Doxofylline WHO GMP packaged for shipment?
A: The product is securely packed in double LDPE bags contained within HDPE drums, each with a net weight of 25 kg, ensuring product integrity during transport.
Q: What process ensures the purity and compliance of Doxofylline WHO GMP?
A: Each batch is validated by IR & HPLC identification methods and tested for loss on drying, heavy metals, and impurities, guaranteeing 99% purity and compliance with IP/BP/USP microbial limits.